It has been shown that KLF6 expression is upregulated in the intestinal tissue of IBD patients and animal models [46], and its chromatin accessibility in MBCs is reduced by IFN-blocking antibody treatment [47]. This evidence concerns the gene IFNA1 and inflammatory bowel disease.